Acceptability of and treatment preferences for recurrent bacterial vaginosis-Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial.

Anstey Watkins, Jocelyn; Ross, Jonathan D C; Thandi, Sukhwinder; Brittain, Clare; Kai, Joe; Griffiths, Frances

Anstey Watkins, Jocelyn; Ross, Jonathan D C; Thandi, Sukhwinder; Brittain, Clare; Kai, Joe; Griffiths, Frances.

Affiliation

Anstey Watkins J; Warwick Medical School, University of Warwick, Coventry, England, United Kingdom.
Ross JDC; University Hospitals Birmingham NHS Foundation Trust, Birmingham, England, United Kingdom.
Thandi S; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, England, United Kingdom.
Brittain C; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, England, United Kingdom.
Kai J; Division of Primary Care, University of Nottingham, Nottingham, England, United Kingdom.
Griffiths F; Warwick Medical School, University of Warwick, Coventry, England, United Kingdom.

PLoS One ; 14(11): e0224964, 2019.

Article de En | MEDLINE | ID: mdl-31730666

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Acceptation des soins par les patients / Vaginose bactérienne / Acide lactique / Préférence des patients / Gels / Métronidazole / Antibactériens Type d'étude: Clinical_trials / Diagnostic_studies / Prognostic_studies / Qualitative_research Aspects: Ethics / Patient_preference Limites: Adult / Female / Humans / Middle aged Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2019 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google